Beximco Pharmaceuticals Limited announced earnings results for the second quarter ended December 31, 2020. For the second quarter, the company announced sales was BDT 7,474.259 million compared to BDT 6,192.191 million a year ago. Operating income was BDT 1,797.100 million compared to BDT 1,324.358 million a year ago. Net income was BDT 1,134.206 million compared to BDT 841.659 million a year ago. Basic earnings per share from continuing operations was BDT 2.54 compared to BDT 1.89 a year ago. For the half year, sales was BDT 14,400.189 million compared to BDT 12,495.526 million a year ago. Operating income was BDT 3,466.868 million compared to BDT 2,757.894 million a year ago. Net income was BDT 2,208.684 million compared to BDT 1,706.419 million a year ago. Basic earnings per share from continuing operations was BDT 4.95 compared to BDT 3.83 a year ago.